{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:48:36Z","timestamp":1770976116456,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81701239"],"award-info":[{"award-number":["81701239"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81771363"],"award-info":[{"award-number":["81771363"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation","award":["18JCYBJC25900"],"award-info":[{"award-number":["18JCYBJC25900"]}]},{"name":"National Key Clinical Specialty Construction Project"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jneuroim.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T22:34:18Z","timestamp":1551134058000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"330","author":[{"given":"Da-Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2019.02.011_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/1673-5374.245465","article-title":"Neuroinflammation as a target for glaucoma therapy","volume":"14","author":"Adornetto","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2019.02.011_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","article-title":"Extracellular HMGB1 as a therapeutic target in inflammatory diseases","volume":"22","author":"Andersson","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2019.02.011_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2019.02.011_bb0020","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","article-title":"Resistin, an adipokine with potent proinflammatory properties","volume":"174","author":"Bokarewa","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2019.02.011_bb0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.17219\/acem\/37225","article-title":"Effects of a tumor necrosis factor-alpha inhibitor (etanercept) on the sciatic nerve in a hypoxic ischemia-induced neonatal rat model","volume":"23","author":"Buyukakilli","year":"2014","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2016.09.022","article-title":"Guillain-Barre syndrome","volume":"16","author":"Esposito","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.jneuroim.2019.02.011_bb0035","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160118","article-title":"IL-1beta\/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells","volume":"36","author":"Fang","year":"2016","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.jneuroim.2019.02.011_bb0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barre syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barre syndrome in northern China. Relationship to campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1423-0127-21-59","article-title":"Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK\/NFkappaB signaling pathway in gastric cancer cells","volume":"21","author":"Hsieh","year":"2014","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12285-8","article-title":"Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-kappaB and HMGB1 pathways through the upregulation of SIRT1","volume":"7","author":"Lan","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.02.011_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.joca.2016.10.002","article-title":"Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-kappaB signaling pathways: implications for intervertebral disc degeneration","volume":"25","author":"Li","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cyto.2018.04.002","article-title":"Activation of the porcine alveolar macrophages via toll-like receptor 4\/NF-kappaB mediated pathway provides a mechanism of resistin leading to inflammation","volume":"110","author":"Li","year":"2018","journal-title":"Cytokine."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","article-title":"Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"47","author":"Maimone","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0075","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pone.0000031","article-title":"Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes","volume":"1","author":"Nagaev","year":"2006","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jneuroim.2019.02.011_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/sji.12464","article-title":"Resistin gene expression is downregulated in CD4(+) T helper lymphocytes and CD14(+) monocytes in rheumatoid arthritis responding to TNF-alpha inhibition","volume":"84","author":"Nagaev","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cca.2016.03.011","article-title":"Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica","volume":"456","author":"Qi","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fimmu.2018.00357","article-title":"Corrigendum: 1,25-Dihydroxyvitamin D inhibits LPS-induced high-mobility group box 1 (HMGB1) secretion via targeting the NF-E2-related factor 2-Hemeoxygenase-1-HMGB1 pathway in macrophages","volume":"9","author":"Rao","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203316646463","article-title":"Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus","volume":"26","author":"Santos","year":"2017","journal-title":"Lupus."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13075-017-1472-0","article-title":"Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"19","author":"Sato","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0105","article-title":"High mobility group box-1 induces pro-inflammatory signaling in human Nucleus Pulposus cells via Toll-like receptor 4-dependent pathway","author":"Shah","year":"2018","journal-title":"J. Orthop. Res."},{"issue":"6","key":"10.1016\/j.jneuroim.2019.02.011_bb0110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/labinvest.2013.61","article-title":"Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis","volume":"93","author":"Sun","year":"2013","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.jneuroim.2019.02.011_bb0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2014-309232","article-title":"Serum high mobility group box 1 is upregulated in myasthenia gravis","volume":"86","author":"Uzawa","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2019.02.011_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cvr\/cvp278","article-title":"Resistin: a newly identified chemokine for human CD4-positive lymphocytes","volume":"85","author":"Walcher","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2019.02.011_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2010.09.017","article-title":"Guillain-Barre syndrome: clinical variants and their pathogenesis","volume":"231","author":"Winer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2015.04.004","article-title":"Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis","volume":"283","author":"Zhang","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0135","article-title":"Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barre syndrome","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2019.02.011_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.02.021","article-title":"PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages","volume":"259","author":"Zuniga","year":"2017","journal-title":"Atherosclerosis."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818305551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818305551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:42Z","timestamp":1759048422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818305551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"alternative-id":["S0165572818305551"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.02.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}